BHC · Business segments
Bausch Health (BHC) revenue by segment
Where Bausch Health’s revenue comes from, as reported in its SEC filings.
Latest quarter: September 30, 2026
Total revenue on the income statement: $2.94B.
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| Product | $2.91B | 99.0% |
| Product and Service, Other | $29M | 1.0% |
Revenue by Segment
| Line | Revenue | Share | Operating income | Margin |
|---|---|---|---|---|
| Bausch + Lomb | $1.38B | 46.8% | $410M | 29.8% |
| Salix | $831M | 28.3% | $716M | 86.2% |
| International Rx | $299M | 10.2% | $99M | 33.1% |
| Diversified | $271M | 9.2% | $195M | 72.0% |
| Solta Medical | $165M | 5.6% | $76M | 46.1% |
Latest year: December 31, 2025
Total revenue on the income statement: $10.27B.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| United States and Puerto Rico | $6.14B | 59.8% |
| Other Countries | $1.15B | 11.2% |
| China | $493M | 4.8% |
| Canada | $417M | 4.1% |
| Poland | $382M | 3.7% |
| Mexico | $278M | 2.7% |
| France | $249M | 2.4% |
| South Korea | $234M | 2.3% |
| Russia | $198M | 1.9% |
| Japan | $192M | 1.9% |
| Germany | $176M | 1.7% |
| United Kingdom | $141M | 1.4% |
| Spain | $109M | 1.1% |
| Italy | $106M | 1.0% |
Revenue by Product
| Line | Revenue | Share |
|---|---|---|
| Pharmaceutical Products | $4.75B | 46.2% |
| Device Products | $2.44B | 23.7% |
| Over the Counter Products | $2.01B | 19.5% |
| Branded and Other Generic Products | $962M | 9.4% |
| Other Revenues | $110M | 1.1% |
| Price Appreciation Credit | $18M | 0.2% |
Revenue by Segment
| Line | Revenue | Share | Operating income | Margin |
|---|---|---|---|---|
| Bausch + Lomb | $5.1B | 49.7% | $1.13B | 22.1% |
| Salix | $2.58B | 25.1% | $1.93B | 74.7% |
| International Rx | $1.13B | 11.0% | $334M | 29.5% |
| Diversified | $937M | 9.1% | $627M | 66.9% |
| Solta Medical | $518M | 5.0% | $232M | 44.8% |
Reading notes
Share is each line’s part of that breakdown. Margin is the company’s reported segment operating income divided by that segment’s revenue. Companies define segment profit differently and may re-cut segments over time, so a company’s lines can differ between years. Breakdowns that do not add up to within 5% of reported revenue are left out.